Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study checks for little-known cholesterol risk in primary care

NCT ID NCT07579325

Knowledge-focused Sponsor: University of Central Florida Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study screens 30 adults at a primary care clinic to find out how many have high levels of lipoprotein(a), a genetic risk factor for heart disease. Participants give a blood sample and researchers measure their cholesterol markers. The goal is to gather data for better heart risk screening in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

35 people

The number who actually took part.

Started

May 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

As any adult patient can be enrolled, no pre-screening will be done. UCFH only sees adult patients.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older * Receiving care at UCF Health primary care clinic * Able to understand and provide informed consent and HIPAA authorization Exclusion Criteria: * Patient self discloses any medical condition that would make venipuncture unsafe * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lipoprotein(A) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lipoprotein(A)

Contacts and locations

Locations

  • University of Central Florida

    Orlando, Florida, 32827, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.